Catalyst Capital Advisors LLC Homology Medicines, Inc. Transaction History

Catalyst Capital Advisors LLC

  • $4.41 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$15.54 - $22.86 $5,081 - $7,475
-327 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$16.49 - $21.55 $1,813 - $2,370
110 Added 50.69%
327 $7,000
Q1 2018

May 18, 2018
BUY
$18.66 - $18.7 $4,049 - $4,057
217 New
217 $4,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Catalyst Capital Advisors LLC Portfolio

Follow Catalyst Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email